Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.

Nava Epstein; Lameh Fananapazir; F Cyran; Gabriel Cohn

doi:10.1161/01.cir.86.2.345

Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.

Nava Epstein(Sheba Medical Center), Lameh Fananapazir(National Heart Lung and Blood Institute), F Cyran(National Heart Lung and Blood Institute), Gabriel Cohn(National Heart Lung and Blood Institute)

Circulation

August 1, 1992

10.1161/01.cir.86.2.345

Cited by 230

|The EMBO Journal|1991|774

Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.

|Circulation|1994|383

Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.

|Journal of Clinical Investigation|1993|242

Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.

|Circulation|1994|226

Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy.

|Proceedings of the National Academy of Sciences|1995|225

Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.

Related Papers